1. Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial. Issue 6 (5th February 2020) Authors: Tricou, Vianney; Low, Jenny G.; Oh, Helen M.; Leo, Yee-Sin; Kalimuddin, Shirin; Wijaya, Limin; Pang, Junxiong; Ling, Li Min; Lee, Tau Hong; Brose, Manja; Hutagalung, Yanee; Rauscher, Martina; Borkowski, Astrid; Wallace, Derek Journal: Vaccine Issue: Volume 38:Issue 6(2020) Page Start: 1513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial. Issue 10234 (2nd May 2020) Authors: Tricou, Vianney; Sáez-Llorens, Xavier; Yu, Delia; Rivera, Luis; Jimeno, José; Villarreal, Ana Cecilia; Dato, Epiphany; Saldaña de Suman, Onix; Montenegro, Nathali; DeAntonio, Rodrigo; Mazara, Sonia; Vargas, Maria; Mendoza, Debbie; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Tuboi, Suely; Bork... Journal: Lancet Issue: Volume 395:Issue 10234(2020) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study. Issue 2 (February 2018) Authors: Sáez-Llorens, Xavier; Tricou, Vianney; Yu, Delia; Rivera, Luis; Jimeno, José; Villarreal, Ana Cecilia; Dato, Epiphany; Mazara, Sonia; Vargas, Maria; Brose, Manja; Rauscher, Martina; Tuboi, Suely; Borkowski, Astrid; Wallace, Derek Journal: Lancet infectious diseases Issue: Volume 18:Issue 2(2018) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination. (15th December 2020) Authors: López-Medina, Eduardo; Biswal, Shibadas; Saez-Llorens, Xavier; Borja-Tabora, Charissa; Bravo, Lulu; Sirivichayakul, Chukiat; Vargas, Luis Martinez; Alera, Maria Theresa; Velásquez, Hector; Reynales, Humberto; Rivera, Luis; Watanaveeradej, Veerachai; Rodriguez-Arenales, Edith Johana; Yu, Delia; Es... Journal: Journal of infectious diseases Issue: Volume 225:Number 9(2022) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study. (13th July 2020) Authors: Sirivichayakul, Chukiat; Barranco-Santana, Elizabeth A; Rivera, Inés Esquilín; Kilbury, Jennifer; Raanan, Marsha; Borkowski, Astrid; Papadimitriou, Athanasia; Wallace, Derek Journal: Journal of infectious diseases Issue: Volume 225:Number 9(2022) Page Start: 1513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of a recombinant, chimeric tetravalent dengue vaccine candidate. Issue 50 (10th December 2015) Authors: Osorio, Jorge E.; Partidos, Charalambos D.; Wallace, Derek; Stinchcomb, Dan T. Journal: Vaccine Issue: Volume 33:Issue 50(2015) Page Start: 7112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting. Issue 8 (16th February 2022) Authors: Tricou, Vianney; Gottardo, Raphael; Egan, Michael A.; Clement, Frédéric; Leroux-Roels, Geert; Sáez-Llorens, Xavier; Borkowski, Astrid; Wallace, Derek; Dean, Hansi J. Journal: Vaccine Issue: Volume 40:Issue 8(2022) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. Issue 6 (June 2017) Authors: Sáez-Llorens, Xavier; Tricou, Vianney; Yu, Delia; Rivera, Luis; Tuboi, Suely; Garbes, Pedro; Borkowski, Astrid; Wallace, Derek Journal: Lancet infectious diseases Issue: Volume 17:Issue 6(2017:Jun.) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003). (4th October 2021) Authors: Rivera, Luis; Biswal, Shibadas; Sáez-Llorens, Xavier; Reynales, Humberto; López-Medina, Eduardo; Borja-Tabora, Charissa; Bravo, Lulu; Sirivichayakul, Chukiat; Kosalaraksa, Pope; Martinez Vargas, Luis; Yu, Delia; Watanaveeradej, Veerachai; Espinoza, Felix; Dietze, Reynaldo; Fernando, LakKumar; Wic... Journal: Clinical infectious diseases Issue: Volume 75:Number 1(2022) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study. Issue 46 (17th November 2015) Authors: Rupp, Richard; Luckasen, Gary Joseph; Kirstein, Judith Lee; Osorio, Jorge E.; Santangelo, Joseph D.; Raanan, Marsha; Smith, Mary Kathryn; Wallace, Derek; Gordon, Gilad S.; Stinchcomb, Dan T. Journal: Vaccine Issue: Volume 33:Issue 46(2015) Page Start: 6351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗